Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Oxcarbazepine Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Oxcarbazepine Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Oxcarbazepine Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Oxcarbazepine Market Size Growth Rate by Type
    • 1.4.2 Tablets (150mg, 300mg, 600mg)
    • 1.4.3 Oral Suspension
  • 1.5 Market by Application
    • 1.5.1 Global Oxcarbazepine Market Size Growth Rate by Application
    • 1.5.2 Pediatric Use (Aged 2-4 years, 4-16 years)
    • 1.5.3 Adult Use
  • 1.6 Coronavirus Disease 2019 (Covid-19): Oxcarbazepine Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Oxcarbazepine Industry
      • 1.6.1.1 Oxcarbazepine Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Oxcarbazepine Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Oxcarbazepine Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Oxcarbazepine Market Size Estimates and Forecasts
    • 2.1.1 Global Oxcarbazepine Revenue 2015-2026
    • 2.1.2 Global Oxcarbazepine Sales 2015-2026
  • 2.2 Oxcarbazepine Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Oxcarbazepine Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Oxcarbazepine Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Oxcarbazepine Competitor Landscape by Players

  • 3.1 Oxcarbazepine Sales by Manufacturers
    • 3.1.1 Oxcarbazepine Sales by Manufacturers (2015-2020)
    • 3.1.2 Oxcarbazepine Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Oxcarbazepine Revenue by Manufacturers
    • 3.2.1 Oxcarbazepine Revenue by Manufacturers (2015-2020)
    • 3.2.2 Oxcarbazepine Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Oxcarbazepine Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Oxcarbazepine Revenue in 2019
    • 3.2.5 Global Oxcarbazepine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Oxcarbazepine Price by Manufacturers
  • 3.4 Oxcarbazepine Manufacturing Base Distribution, Product Types
    • 3.4.1 Oxcarbazepine Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Oxcarbazepine Product Type
    • 3.4.3 Date of International Manufacturers Enter into Oxcarbazepine Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Oxcarbazepine Market Size by Type (2015-2020)
    • 4.1.1 Global Oxcarbazepine Sales by Type (2015-2020)
    • 4.1.2 Global Oxcarbazepine Revenue by Type (2015-2020)
    • 4.1.3 Oxcarbazepine Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Oxcarbazepine Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Oxcarbazepine Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Oxcarbazepine Revenue Forecast by Type (2021-2026)
    • 4.2.3 Oxcarbazepine Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Oxcarbazepine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Oxcarbazepine Market Size by Application (2015-2020)
    • 5.1.1 Global Oxcarbazepine Sales by Application (2015-2020)
    • 5.1.2 Global Oxcarbazepine Revenue by Application (2015-2020)
    • 5.1.3 Oxcarbazepine Price by Application (2015-2020)
  • 5.2 Oxcarbazepine Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Oxcarbazepine Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Oxcarbazepine Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Oxcarbazepine Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Oxcarbazepine by Country
    • 6.1.1 North America Oxcarbazepine Sales by Country
    • 6.1.2 North America Oxcarbazepine Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Oxcarbazepine Market Facts & Figures by Type
  • 6.3 North America Oxcarbazepine Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Oxcarbazepine by Country
    • 7.1.1 Europe Oxcarbazepine Sales by Country
    • 7.1.2 Europe Oxcarbazepine Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Oxcarbazepine Market Facts & Figures by Type
  • 7.3 Europe Oxcarbazepine Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Oxcarbazepine by Region
    • 8.1.1 Asia Pacific Oxcarbazepine Sales by Region
    • 8.1.2 Asia Pacific Oxcarbazepine Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Oxcarbazepine Market Facts & Figures by Type
  • 8.3 Asia Pacific Oxcarbazepine Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Oxcarbazepine by Country
    • 9.1.1 Latin America Oxcarbazepine Sales by Country
    • 9.1.2 Latin America Oxcarbazepine Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Oxcarbazepine Market Facts & Figures by Type
  • 9.3 Central & South America Oxcarbazepine Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Oxcarbazepine by Country
    • 10.1.1 Middle East and Africa Oxcarbazepine Sales by Country
    • 10.1.2 Middle East and Africa Oxcarbazepine Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Oxcarbazepine Market Facts & Figures by Type
  • 10.3 Middle East and Africa Oxcarbazepine Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Novartis (Trileptal)
    • 11.1.1 Novartis (Trileptal) Corporation Information
    • 11.1.2 Novartis (Trileptal) Description, Business Overview and Total Revenue
    • 11.1.3 Novartis (Trileptal) Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Novartis (Trileptal) Oxcarbazepine Products Offered
    • 11.1.5 Novartis (Trileptal) Recent Development
  • 11.2 Supernus Pharmaceuticals (Oxtellar XR)
    • 11.2.1 Supernus Pharmaceuticals (Oxtellar XR) Corporation Information
    • 11.2.2 Supernus Pharmaceuticals (Oxtellar XR) Description, Business Overview and Total Revenue
    • 11.2.3 Supernus Pharmaceuticals (Oxtellar XR) Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Products Offered
    • 11.2.5 Supernus Pharmaceuticals (Oxtellar XR) Recent Development
  • 11.3 Sun Pharm
    • 11.3.1 Sun Pharm Corporation Information
    • 11.3.2 Sun Pharm Description, Business Overview and Total Revenue
    • 11.3.3 Sun Pharm Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Sun Pharm Oxcarbazepine Products Offered
    • 11.3.5 Sun Pharm Recent Development
  • 11.4 Ranbaxy Pharmaceuticals
    • 11.4.1 Ranbaxy Pharmaceuticals Corporation Information
    • 11.4.2 Ranbaxy Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.4.3 Ranbaxy Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Ranbaxy Pharmaceuticals Oxcarbazepine Products Offered
    • 11.4.5 Ranbaxy Pharmaceuticals Recent Development
  • 11.5 Jubilant Generics
    • 11.5.1 Jubilant Generics Corporation Information
    • 11.5.2 Jubilant Generics Description, Business Overview and Total Revenue
    • 11.5.3 Jubilant Generics Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Jubilant Generics Oxcarbazepine Products Offered
    • 11.5.5 Jubilant Generics Recent Development
  • 11.6 Taro Pharmaceuticals
    • 11.6.1 Taro Pharmaceuticals Corporation Information
    • 11.6.2 Taro Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.6.3 Taro Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Taro Pharmaceuticals Oxcarbazepine Products Offered
    • 11.6.5 Taro Pharmaceuticals Recent Development
  • 11.7 Mylan
    • 11.7.1 Mylan Corporation Information
    • 11.7.2 Mylan Description, Business Overview and Total Revenue
    • 11.7.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Mylan Oxcarbazepine Products Offered
    • 11.7.5 Mylan Recent Development
  • 11.8 Stada Group
    • 11.8.1 Stada Group Corporation Information
    • 11.8.2 Stada Group Description, Business Overview and Total Revenue
    • 11.8.3 Stada Group Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Stada Group Oxcarbazepine Products Offered
    • 11.8.5 Stada Group Recent Development
  • 11.9 Glenmark Pharmaceuticals
    • 11.9.1 Glenmark Pharmaceuticals Corporation Information
    • 11.9.2 Glenmark Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.9.3 Glenmark Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Glenmark Pharmaceuticals Oxcarbazepine Products Offered
    • 11.9.5 Glenmark Pharmaceuticals Recent Development
  • 11.10 ANI Pharmaceuticals
    • 11.10.1 ANI Pharmaceuticals Corporation Information
    • 11.10.2 ANI Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.10.3 ANI Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 ANI Pharmaceuticals Oxcarbazepine Products Offered
    • 11.10.5 ANI Pharmaceuticals Recent Development
  • 11.1 Novartis (Trileptal)
    • 11.1.1 Novartis (Trileptal) Corporation Information
    • 11.1.2 Novartis (Trileptal) Description, Business Overview and Total Revenue
    • 11.1.3 Novartis (Trileptal) Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Novartis (Trileptal) Oxcarbazepine Products Offered
    • 11.1.5 Novartis (Trileptal) Recent Development
  • 11.12 Roxane Laboratories
    • 11.12.1 Roxane Laboratories Corporation Information
    • 11.12.2 Roxane Laboratories Description, Business Overview and Total Revenue
    • 11.12.3 Roxane Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Roxane Laboratories Products Offered
    • 11.12.5 Roxane Laboratories Recent Development
  • 11.13 Nobelpharma
    • 11.13.1 Nobelpharma Corporation Information
    • 11.13.2 Nobelpharma Description, Business Overview and Total Revenue
    • 11.13.3 Nobelpharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Nobelpharma Products Offered
    • 11.13.5 Nobelpharma Recent Development
  • 11.14 Apotex
    • 11.14.1 Apotex Corporation Information
    • 11.14.2 Apotex Description, Business Overview and Total Revenue
    • 11.14.3 Apotex Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 Apotex Products Offered
    • 11.14.5 Apotex Recent Development
  • 11.15 Nexgen pharma
    • 11.15.1 Nexgen pharma Corporation Information
    • 11.15.2 Nexgen pharma Description, Business Overview and Total Revenue
    • 11.15.3 Nexgen pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.15.4 Nexgen pharma Products Offered
    • 11.15.5 Nexgen pharma Recent Development
  • 11.16 Amneal Pharmaceuticals
    • 11.16.1 Amneal Pharmaceuticals Corporation Information
    • 11.16.2 Amneal Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.16.3 Amneal Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.16.4 Amneal Pharmaceuticals Products Offered
    • 11.16.5 Amneal Pharmaceuticals Recent Development
  • 11.17 Hikma Pharmaceuticals
    • 11.17.1 Hikma Pharmaceuticals Corporation Information
    • 11.17.2 Hikma Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.17.3 Hikma Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.17.4 Hikma Pharmaceuticals Products Offered
    • 11.17.5 Hikma Pharmaceuticals Recent Development
  • 11.18 Jamp Pharma
    • 11.18.1 Jamp Pharma Corporation Information
    • 11.18.2 Jamp Pharma Description, Business Overview and Total Revenue
    • 11.18.3 Jamp Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.18.4 Jamp Pharma Products Offered
    • 11.18.5 Jamp Pharma Recent Development
  • 11.19 Neuraxpharm
    • 11.19.1 Neuraxpharm Corporation Information
    • 11.19.2 Neuraxpharm Description, Business Overview and Total Revenue
    • 11.19.3 Neuraxpharm Sales, Revenue and Gross Margin (2015-2020)
    • 11.19.4 Neuraxpharm Products Offered
    • 11.19.5 Neuraxpharm Recent Development
  • 11.20 Orion Corporation
    • 11.20.1 Orion Corporation Corporation Information
    • 11.20.2 Orion Corporation Description, Business Overview and Total Revenue
    • 11.20.3 Orion Corporation Sales, Revenue and Gross Margin (2015-2020)
    • 11.20.4 Orion Corporation Products Offered
    • 11.20.5 Orion Corporation Recent Development
  • 11.21 Sihuan Pharm
    • 11.21.1 Sihuan Pharm Corporation Information
    • 11.21.2 Sihuan Pharm Description, Business Overview and Total Revenue
    • 11.21.3 Sihuan Pharm Sales, Revenue and Gross Margin (2015-2020)
    • 11.21.4 Sihuan Pharm Products Offered
    • 11.21.5 Sihuan Pharm Recent Development
  • 11.22 Humanwell Healthcare
    • 11.22.1 Humanwell Healthcare Corporation Information
    • 11.22.2 Humanwell Healthcare Description, Business Overview and Total Revenue
    • 11.22.3 Humanwell Healthcare Sales, Revenue and Gross Margin (2015-2020)
    • 11.22.4 Humanwell Healthcare Products Offered
    • 11.22.5 Humanwell Healthcare Recent Development
  • 11.23 Huikang Pharmaceutical
    • 11.23.1 Huikang Pharmaceutical Corporation Information
    • 11.23.2 Huikang Pharmaceutical Description, Business Overview and Total Revenue
    • 11.23.3 Huikang Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.23.4 Huikang Pharmaceutical Products Offered
    • 11.23.5 Huikang Pharmaceutical Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Oxcarbazepine Market Estimates and Projections by Region
    • 12.1.1 Global Oxcarbazepine Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Oxcarbazepine Revenue Forecast by Regions 2021-2026
  • 12.2 North America Oxcarbazepine Market Size Forecast (2021-2026)
    • 12.2.1 North America: Oxcarbazepine Sales Forecast (2021-2026)
    • 12.2.2 North America: Oxcarbazepine Revenue Forecast (2021-2026)
    • 12.2.3 North America: Oxcarbazepine Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Oxcarbazepine Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Oxcarbazepine Sales Forecast (2021-2026)
    • 12.3.2 Europe: Oxcarbazepine Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Oxcarbazepine Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Oxcarbazepine Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Oxcarbazepine Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Oxcarbazepine Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Oxcarbazepine Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Oxcarbazepine Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Oxcarbazepine Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Oxcarbazepine Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Oxcarbazepine Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Oxcarbazepine Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Oxcarbazepine Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Oxcarbazepine Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Oxcarbazepine Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Oxcarbazepine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Oxcarbazepine Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Oxcarbazepine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oxcarbazepine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Oxcarbazepine market is segmented into
    Tablets (150mg, 300mg, 600mg)
    Oral Suspension

    Segment by Application, the Oxcarbazepine market is segmented into
    Pediatric Use (Aged 2-4 years, 4-16 years)
    Adult Use

    Regional and Country-level Analysis
    The Oxcarbazepine market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Oxcarbazepine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Oxcarbazepine Market Share Analysis
    Oxcarbazepine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oxcarbazepine business, the date to enter into the Oxcarbazepine market, Oxcarbazepine product introduction, recent developments, etc.
    The major vendors covered:
    Novartis (Trileptal)
    Supernus Pharmaceuticals (Oxtellar XR)
    Sun Pharm
    Ranbaxy Pharmaceuticals
    Jubilant Generics
    Taro Pharmaceuticals
    Mylan
    Stada Group
    Glenmark Pharmaceuticals
    ANI Pharmaceuticals
    Teva Pharmaceutical
    Roxane Laboratories
    Nobelpharma
    Apotex
    Nexgen pharma
    Amneal Pharmaceuticals
    Hikma Pharmaceuticals
    Jamp Pharma
    Neuraxpharm
    Orion Corporation
    Sihuan Pharm
    Humanwell Healthcare
    Huikang Pharmaceutical

    Buy now